A study to assess how much drug reaches the blood when given from Symbicort pMDI with spacer compared to that of Symbicort pMDI without spacer in healthy volunteers

Trial Identifier: D589WC00001
Sponsor: AstraZeneca
Collaborator:
PAREXEL
NCTID:: NCT02934607
Start Date: November 2016
Primary Completion Date: March 2017
Study Completion Date: March 2017
Condition: Healthy Volunteers

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

Language Description
English translation

Trial Locations

Country Location
United Kingdom Harrow, United Kingdom, HA1 3UJ